Yahoo Movies3 High-Yield Dividend Stocks I'd Buy Right Now
If you're looking to get even on odd-sized returns, I have three stock picks yielding 3%, 5%, and 7% for you.
If you're looking to get even on odd-sized returns, I have three stock picks yielding 3%, 5%, and 7% for you.
Kroll Bond Rating Agency (KBRA) assigns preliminary ratings to three classes of notes issued by ICG US CLO 2021-2, Ltd. (ICG US CLO 2021-2), a cash flow collateralized loan obligation (CLO) back by a diversified portfolio of broadly syndicated corporate loans.
Pot producer Green Thumb Industries Inc said it would make and distribute Gwyneth Paltrow-backed CBD-infused sparkling water "Cann" across the U.S, banking on the brand's early success in California and rising demand for cannabis drinks. Green Thumb, among the largest U.S. cannabis companies by market value, said on Wednesday it would begin distributing Cann in Illinois this spring and later expand to additional markets, including New Jersey, which recently legalized recreational marijuana. Top cannabis operators across North America are trying to establish early dominance in the drinks market, a product considered to be more socially accepted than smoking is.
Greg Evans, a Black man who joined a parade of witnesses urging Oregon lawmakers to ban the display of nooses, said the issue was personal for him: A member of his family had been lynched over a century ago in South Carolina. “He was killed basically for offending a white man,” Evans, a member of the Eugene City Council, testified Tuesday. Louisiana, Virginia, California, New York, Maryland and Connecticut previously criminalized the display of nooses.
Myanmar's deputy U.N. ambassador, who was assigned by the military to head the country’s mission to the United Nations after the ambassador strongly opposed their recent coup, resigned on Wednesday, according to social media and newspaper reports. Tin Maung Naing was named by the Ministry of Foreign Affairs as the mission’s charge d’affaires in a letter to U.N. Secretary-General Antonio Guterres received Tuesday. It said Ambassador Kyaw Moe Tun had been terminated.
Rivkah Reyes became famous at age 10 after "School of Rock." The now 28-year-old is getting candid about the pitfalls of child fame in a new interview.
The latest developments come just days before the couple’s ‘tell-all’ television interview with Oprah Winfrey is due to air.
The failure to hire and promote qualified women and racially diverse workers is making it impossible for the labor market to reach its full potential, a new report found.
Cameron Swartz scored a career-high 33 points and 13th-seeded Boston College opened the Atlantic Coast Conference tournament with a 67-56 win over 12th-seeded Pittsburgh on Wednesday. Swartz matched her career-high with four 3-pointers and the career 72% shooter from the foul line made 15 of 16 free throws, the first time she shot more than seven in a game. Makayla Dickens had three 3s and 11 points for the Eagles (7-11), who play fifth-seeded Syracuse on Thursday.
Prime Minister Justin Trudeau expressed optimism Wednesday that his government's timeline for vaccinating Canadians against COVID-19 could be accelerated as more shots are approved and guidelines for administering them evolve. The federal government's plan to have doses administered to all Canadians who want one by the end of September didn't factor in the arrival of new vaccines such as the Oxford-AstraZeneca shot, Trudeau said in a news conference. And despite delays in the delivery of the Pfizer-BioNTech vaccine last month, Canada is now "fully back on track and even ahead of schedule" when it comes to its supply of the various shots, he said, noting the country should receive more than the six million doses of COVID-19 vaccines it initially expected to get by the end of March. "The projections we've had for many, many months certainly hold, but we're also very optimistic that they're going to be able to be moved forward if, indeed, all the vaccines that we've contracted for are able to be manufactured and shipped in the right ways," the prime minister said. Any change in the public health guidance regarding the time allowed between the first and second doses of a vaccine could also affect Canada's rollout, Trudeau said. "We're seeing some of the science shift, some proposals put forward which are very, very interesting, which could result in rapider timelines, but every step of the way we're going to be informed by the experts, by the science," he said. Newfoundland and Labrador said Wednesday it is extending the interval between the first and second doses to four months, days after health officials in British Columbia announced they were doing so. Manitoba followed suit later Wednesday, though health officials there said they would work out the details in accordance with guidelines issued by a national panel of vaccine experts. The province also said second-dose appointments booked prior to the change would go ahead as scheduled. Ontario has said it is weighing a similar move but seeking advice from the federal government. Meanwhile, the first 500,000 doses of the recently approved Oxford-AstraZeneca vaccine arrived in Canada on Wednesday, though confusion persists over who should get them. The vaccine, manufactured at the Serum Institute of India, is the third COVID-19 shot approved for use in Canada. Health Canada last week authorized its use for all adult Canadians but the National Advisory Committee on Immunization recommended Tuesday that it not be administered to people 65 years of age or older. The committee said there is limited data from clinical trials about how effective the Oxford-AstraZeneca vaccine is for seniors and recommends that they be given priority for the two other vaccines — Pfizer-BioNTech and Moderna — already greenlighted for use in Canada. Both Health Canada and the committee stress no safety concerns have arisen in the clinical studies or among the millions of seniors who have received the Oxford-AstraZeneca vaccine in other countries. Indeed, Dr. Supriya Sharma, chief medical adviser at Health Canada, insists there's no real contradiction between what her department and the advisory committee are saying: both agree that where possible, it's preferable to give seniors the Pfizer or Moderna vaccines, which have proven in clinical trials to be more effective in guarding older people against COVID-19. That said, Sharma said seniors shouldn't wait for a Pfizer or Moderna shot if they can get an Oxford-AstraZeneca jab sooner. Real-world evidence, she said, shows the AstraZeneca vaccine is effective at preventing serious cases of COVID-19, hospitalizations and deaths. Some provinces, including Alberta, British Columbia and Prince Edward Island, plan to follow the advisory committee's advice and target the Oxford-AstraZeneca vaccine at younger people working in front-line essential services or in high-risk settings like prisons. On Wednesday, the Ontario government said it will give the Oxford-AstraZeneca shot to residents aged 60 to 64. The drug will not be doled out through mass immunization clinics but rather through a "different pathway," Solicitor General Sylvia Jones said. Details of the program were not released. Manitoba said it plans to target those between the ages of 50 and 64 who have high-risk underlying conditions. The province said it expects to receive its first shipment of the AstraZeneca shot by mid-month. Other provinces, including Quebec, New Brunswick and Nova Scotia, are still mulling over the issue. New guidelines for shipping and storing the Pfizer-BioNTech vaccine were also released Wednesday, with Health Canada saying the drug can be transported and kept at standard freezer temperatures for up to two weeks. The previous storage instructions required that the vaccine be kept in ultralow temperatures and thawed just before use, which restricted its distribution to areas equipped with the necessary specialty freezers. The change should allow for wider distribution of the vaccines. Ottawa also confirmed Wednesday it is extending three federal support programs meant to lessen the economic impact of COVID-19 on residents and business owners until June. The federal wage subsidy, rent support and lockdown programs will carry on with the same level of aid, the government said. In addition to Wednesday's shipment of Oxford-AstraZeneca doses, Canada is also scheduled to receive 444,600 doses of the Pfizer vaccine this week. With Oxford-AstraZeneca added to Canada's vaccine arsenal, the country is on track to receive a total of 6.5 million vaccine doses by the end of this month — half a million more than originally expected. This report by The Canadian Press was first published March 3, 2021. Paola Loriggio, The Canadian Press
BrainChip’s Success in 2020 Advances Fields of On-Chip Learning and Ultra-Low Power Edge AI
HALIFAX — Federal Fisheries Minister Bernadette Jordan released a plan Wednesday outlining conditions for Indigenous lobster fishers to participate in moderate livelihood fisheries during commercial seasons. The Assembly of Nova Scotia Mi’kmaw Chiefs, however, said Ottawa's latest overture is "unacceptable." Jordan said her plan would allow moderate livelihood fishing activity during the commercial, federally regulated season, through licences issued under the Fisheries Act. She said her idea wouldn't increase the total amount of fishing conducted in the country's waters. "I need to make sure the stocks are health and sustainable," she said in an interview Wednesday. "And we have the seasons for that purpose: to make sure that this is orderly, it's regulated and it does meet our conservation objectives." The plan would also allow First Nations communities to sell moderate livelihood catches to processors, which is currently illegal under Nova Scotia regulations. "The difference is we are now authorizing a moderate livelihood fishery, which is completely separate from a commercial fishery," Jordan said. She said the plan — which she said can be long-term or yearly — can be used while First Nations communities and the government negotiate an overarching Rights Reconciliation Agreement on Indigenous fishing rights. She said there are a number of banked licences that can be used to give access to First Nations communities, adding that she hopes there can be some voluntary buyouts of existing commercial licences. The Fisheries Department, she said, will work with First Nations communities to develop moderate livelihood fishing plans that could be unique to each community. The minister said the interim plan is a "path" that is "flexible and adaptable" and is based in the implementation of First Nations treaty rights, the conservation and sustainability of fish stocks, and transparent management of the fishery. The Sipekne'katik and Potlotek First Nations have launched lawsuits against the Nova Scotia government, with both saying existing regulations interfere with their treaty right to fish in pursuit of a moderate livelihood. Indigenous fishers in Nova Scotia argue that a 1999 Supreme Court of Canada decision affirms the Mi'kmaq treaty right to fish for a "moderate livelihood'' when and where they want — even outside the federally regulated commercial fishing season. That decision was later clarified by the court, however, which said Ottawa could regulate the Mi'kmaq treaty right for conservation and other limited purposes. Sipekne'katik Chief Mike Sack said his band is not impressed with the government's new plan. The First Nation launched its own moderate livelihood fishery last fall in St. Mary's Bay, outside of the federally regulated season. Members of the band encountered violence from non-Indigenous residents that resulted in the destruction of a lobster pound and the burning of a band member's van. Sack said it was "kind of the same old stuff" when asked about Jordan's plan. "We are strongly for not having the department issue our licences and we want to exercise our right and have our own season," he said. "It's way off the mark." Sack said Sipekne'katik plans to go ahead with its own fishery this spring, likely in June. Meanwhile, the Assembly of Nova Scotia Mi'kmaw Chiefs said in a news release on Wednesday the plan by the Department of Fisheries and Oceans was "unacceptable." "Minister Bernadette Jordan ... has also made unilateral decisions and asserted a position ... having full control over our Rights-based fishery. This is unacceptable. "DFO is continuing to impose rules without consultation with, accommodation of, or agreement with, the Assembly." Gordon Beaton, president of Local 4 of the Maritime Fishermen's Union, said commercial fishers are open to allowing First Nations participation as long as any agreement adheres to three primary pillars: in-season fishing only, no overall increased fishing, and the same basic rules for all fishers. "If there is some different kind of access, the industry has no problem with that as long as it's under the same rules," Beaton said. "As always, it will be what's in the (plan's) details." This report by The Canadian Press was first published March 3, 2021. Keith Doucette, The Canadian Press
WASHINGTON — House Democrats are poised to pass a sweeping elections and ethics bill, offering it up as a powerful counterweight to voting rights restrictions advancing in Republican-controlled statehouses across the country. House Resolution 1, which touches on virtually every aspect of the electoral process, would restrict partisan gerrymandering of congressional districts, strike down hurdles to voting and bring transparency to a murky campaign finance system that allows wealthy donors to anonymously bankroll political causes. This bill “will put a stop at the voter suppression that we’re seeing debated right now,” said Rep. Nikema Williams, a new congresswoman who represents the Georgia district that deceased voting rights champion John Lewis held for years. “This bill is the ‘Good Trouble’ he fought for his entire life.” To Republicans, though, it would herald a massive expansion of the federal government's role in elections, infringing on states that limit ballot access in the name of election security. “If this were to become law it would be the largest expansion of the federal government's role in our elections that we’ve ever seen,” said Rep. Rodney Davis, R-Ill. The stakes are monumental, cutting to the foundational idea that one person equals one vote and could shape election outcomes for years to come. The push comes after decades of court decisions and Republican-championed state laws that have imposed limits that have fallen hardest on key constituencies of the Democratic Party. The measure, which was all but certain to pass the House in a vote expected Wednesday, has been a priority for Democrats since they won their majority in 2018. But it has taken on added urgency in the wake of Donald Trump’s repeated false claims of a stolen 2020 election. Courts and even Trump's last attorney general, William Barr, found his claims about the election to be without merit. But, spurred on by those lies, state lawmakers across the U.S. have filed more than 200 bills in 43 states that would limit ballot access, according to a tally kept by the Brennan Center for Justice at New York University. In Iowa, the legislature has voted to cut absentee and in-person early voting and prevent local elections officials from setting up additional locations to make early voting easier. In Georgia, the House on Monday voted for a law to require identification to vote by mail and allow counties to cancel early in-person voting on Sundays, when many Black voters cast ballots after church. On Tuesday, the Supreme Court appeared ready to uphold voting restrictions in Arizona, which could make it harder to challenge state election laws in the future. When asked why proponents sought to uphold the Arizona laws, which limit who can turn in absentee ballots and enable ballots to be thrown out if they are cast in the wrong precinct, a lawyer for the state's Republican Party was stunningly clear. “Because it puts us at a competitive disadvantage relative to Democrats,” said attorney Michael Carvin. “Politics is a zero-sum game." Battle lines are quickly being drawn by outside groups who plan to spend millions of dollars on advertising and outreach campaigns. Republicans “are not even being coy about it. They are saying the ‘quiet parts’ out loud,” said Tiffany Muller, the president of End Citizens United, a left-leaning group that aims to curtail the influence of corporate money in politics. Her group has launched a $10 million effort supporting the bill. “For them, this isn’t about protecting our democracy or protecting our elections. This is about pure partisan political gain.” That’s the same charge Republicans level at Democrats. “Democrats want to use their razor-thin majority not to pass bills to earn voters’ trust, but to ensure they don’t lose more seats in the next election,” House Minority Leader Kevin McCarthy said from the House floor on Tuesday. A coalition led by Ken Cuccinelli, a former Trump administration official in the Department of Homeland Security, will spend $5 million pressuring moderate Democratic senators to oppose the bill. “The imperative is stopping H.R. 1 because it’s that bad,” said Cuccinelli. “H.R. 1 is not about making elections better. In fact, it's about the opposite. It's intended to dirty up elections.” So what's actually in the bill? H.R. 1 would require states to automatically register eligible voters and offer same-day registration. It would limit states' ability to purge registered voters from their rolls and mandate the restoration of former felons' voting rights in states where they aren't allowed to vote. Among dozens of other provisions, it would also require states to offer 15 days of early voting and allow no-excuse absentee balloting. On the cusp of a once-in-a-decade redrawing of congressional district boundaries, typically a fiercely partisan affair, the bill would mandate that nonpartisan commissions handle the process instead of state legislatures. Many Republican opponents in Congress have homed in on narrower aspects of the measure though, railing against the creation of a public financing system for congressional campaigns. Davis charged that it would “launder corporate dollars” to publicly fund congressional campaigns. What the bill would actually do is use fines and settlement proceeds raised from corporate bad actors to create a pool of money open to candidates who meet certain requirements. Republicans similarly attacked an effort to revamp the federal government's toothless elections cop. That agency, the Federal Election Commission, has been gripped by partisan deadlock for years, allowing campaign finance law violators to go mostly unchecked. They've also excoriated a section that would force the disclosure of donors to “dark money” political groups. It “would put people’s private information on display and put their personal security at risk,” said Rep. Debbie Lesko, R-Ariz. “People could lose their jobs, be shamed or even worse.” Most campaigns and political groups are already required to disclose donor information. But over the past decade “dark money” nonprofits, which are not required to reveal such information under IRS law, have risen to prominence, often because they are attractive to wealthy interests that wish to remain anonymous. Still, the biggest obstacles lie ahead in the Senate, which is split 50-50 between Republicans and Democrats. On some legislation, it takes only 51 votes to pass, with Vice-President Kamala Harris as the tiebreaker. On a deeply divisive bill like this one, they would need 60 votes under the Senate’s rules to overcome a Republican filibuster — a tally they are unlikely to reach. Some have discussed options like lowering the threshold to break a filibuster, or creating a workaround that would allow some legislation to be exempt. Democratic congressional aides say the conversations are fluid but underway. Brian Slodysko, The Associated Press
Canes’ Andrei Svechnikov, Detroit’s Evgeny have never played against each other in a game during their hockey careers.
Air Canada's stock price continues to suffer from an industry in tatters, but Ballard Power stock has fuel cell growth tailwinds propelling it higher. The post Air Canada (TSX:AC) Stock Pales in Comparison to This Fuel Cell Stock appeared first on The Motley Fool Canada.
DLTR earnings call for the period ending January 30, 2021.
Chinese exhibitors should stop wantonly raising movie ticket prices or else prepare to face consumer backlash, a key government-affiliated consumer rights body said in a new report. The high price of movie tickets was one of the top categories of consumer complaints over the country’s big Chinese New Year holiday, according to the China Consumers […]
FLORHAM PARK, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced that Frank Bedu-Addo, CEO of PDS Biotech, will present at the H.C. Wainwright Global Life Sciences Conference being held from March 9-10, and at the 31st Annual Oppenheimer Healthcare Conference being held from March 16-18. Both conferences are being hosted virtually. H.C. Wainwright & Co. Global Life Sciences ConferenceDate: Presentation Available On-Demand March 9-10, 2021Registration: Click Here 31st Annual Oppenheimer Healthcare ConferenceDate: March 16, 2021 at 1:10 PM Eastern TimeRegistration: Click Here Replays of the presentations will be available online in the investor relations section of the Company’s website for 90 days following the events. About PDS Biotechnology PDS Biotech is a clinical-stage immunotherapy company with a growing pipeline of cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology platform. Versamune® effectively delivers disease-specific antigens for in vivo uptake and processing, while also activating the critical type 1 interferon immunological pathway, resulting in production of potent disease-specific killer T-cells as well as neutralizing antibodies. PDS Biotech has engineered multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize disease cells and effectively attack and destroy them. To learn more, please visit www.pdsbiotech.com or follow us on Twitter at @PDSBiotech. Forward Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning PDS Biotechnology Corporation (the “Company”) and other matters. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of the Company’s management, as well as assumptions made by, and information currently available to, management. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” “forecast.” “guidance”, “outlook” and other similar expressions among others. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the Company’s ability to protect its intellectual property rights; the Company’s anticipated capital requirements, including the Company’s anticipated cash runway and the Company’s current expectations regarding its plans for future equity financings; the Company’s dependence on additional financing to fund its operations and complete the development and commercialization of its product candidates, and the risks that raising such additional capital may restrict the Company’s operations or require the Company to relinquish rights to the Company’s technologies or product candidates; the Company’s limited operating history in the Company’s current line of business, which makes it difficult to evaluate the Company’s prospects, the Company’s business plan or the likelihood of the Company’s successful implementation of such business plan; the timing for the Company or its partners to initiate the planned clinical trials for its lead asset PDS0101; the future success of such trials; the successful implementation of the Company’s research and development programs and collaborations, including any collaboration studies concerning PDS0101 and the Company’s interpretation of the results and findings of such programs and collaborations and whether such results are sufficient to support the future success of the Company’s product candidates; the acceptance by the market of the Company’s product candidates, if approved; the timing of and the Company’s ability to obtain and maintain U.S. Food and Drug Administration or other regulatory authority approval of, or other action with respect to, the Company’s product candidates; and other factors, including legislative, regulatory, political and economic developments not within the Company’s control, including unforeseen circumstances or other disruptions to normal business operations arising from or related to COVID-19. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the risk factors included in the Company’s annual and periodic reports filed with the SEC. The forward-looking statements are made only as of the date of this press release and, except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Media & Investor Relations Contact: Deanne RandolphPDS BiotechPhone: +1 (908) 517-3613Email: drandolph@pdsbiotech.com Jacob GoldbergerCG CapitalPhone: +1 (404) 736-3841Email: jacob@cg.capital
ROCKAWAY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management will participate in two upcoming investor conferences. H.C. Wainwright Global Life Sciences ConferenceFormat: pre-recorded fireside chat followed by 1x1 virtual investor meetingsDate: March 9 – 10 The fireside chat will be available for viewing beginning on Tuesday, March 9, 2021 at 7:00 a.m. ET. Following the conference a webcast replay of the presentation will be available for 90 days on the Investor section of the company’s website, www.electrocore.com M Vest LLC and Maxim Group LLC Emerging Growth Virtual ConferenceFormat: pre-recorded corporate presentation followed by 1x1 virtual investor meetingsDate: March 17 – 18 The presentation will be available for viewing beginning on Wednesday, March 17, 2021 at 9:00 a.m. ET. Investors can register for the conference HERE. About electroCore, Inc. electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients. For more information, visit www.electrocore.com. Investors: Hans VitzthumLifeSci Advisors617-430-7578hans@lifesciadvisors.com or Media Contact: Summer DiazelectroCore973-290-0097summer.diaz@electrocore.com
Studio397 brand and name to remain under Motorsport Games banner Updates and iteration of rFactor 2 to continue under Studio397 MIAMI, March 03, 2021 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”), a leading racing game developer, publisher and esports ecosystem provider of official motorsport racing series throughout the world, announced today that it has entered a binding term sheet to acquire Studio397 BV, the company behind the industry leading rFactor 2 racing simulation platform, from Luminis International BV. The acquisition will see Studio397 continue its work on rFactor 2 while also developing the physics and handling models for Motorsport Games’ forthcoming projects. Motorsport Games expects to utilize its resources and expertise to enhance the rFactor 2 offering, especially in areas highlighted by the racing community. Studio397 and Motorsport Games have long worked in tandem, with rFactor 2 providing the simulation platform for the highly successful 24 Hours of Le Mans Virtual race, as well as the Formula E Race at Home Challenge, both of which were operated by Motorsport Games. It is expected that Studio397 will retain its name and branding with the existing development team and management will remain with the studio. “We have been working with the team at Studio397 for a long time on both game development and esports. This is an acquisition that, when completed, makes complete sense for all parties and we are delighted to have them agree to join the Motorsport Games family,” said Stephen Hood, President of Motorsport Games. “Studio397 has a clear passion for virtual racing and together we recognised an opportunity to work as one team to advance the genre to the next level,” continued Hood. “We see this as great news for the sim racing community as we can now leverage the best elements of the rFactor 2 platform, combine it with our foundational use of Unreal Engine (developed by Epic Games) and layer in the additional components our talented teams have spent the last two years developing. Our aim was to start out with a product that had heart and soul. When the planned acquisition is completed, we can operate safe in the knowledge that another piece of an ambitious puzzle has been secured.” “After growing rFactor 2 in the last five years, we are excited to take the next step with Motorsport Games, advancing rFactor 2 and integrating its advanced simulation technology into future projects. We share a common ambition to be the best at what we do,” said Marcel Offermans, Managing Director, Studio397. “This planned acquisition is another clear signal of our intention to establish Motorsport Games as the leader in the virtual racing space. We continue to utilize the capital committed by our shareholders to aggressively pursue our goals,” added Dmitry Kozko, CEO of Motorsport Games. “Securing rFactor 2 and the expertise behind it will be a huge advancement for us. We will bring our experience and knowledge to help maximize the potential of the rFactor 2 platform while also having exclusive access to its best-in-class technology for our future projects.” “The level of simulation and the feeling of driving offered by rFactor 2 is second to none,” shared Fernando Alonso, Motorsport Games shareholder, Alpine Formula 1 driver and two-time Formula 1 World Drivers’ Champion. “I am delighted that Studio397 and rFactor 2 will be joining our Motorsport Games family and I am sure that we will enjoy a great deal of success together.” This latest announcement from Motorsport Games follows a string of exciting developments, including the upcoming acquisition of KartKraft from Black Delta and announcements of forthcoming games based upon the iconic 24 Hours of Le Mans and the British Touring Car Championship, in addition to the company’s existing NASCAR projects. For more information about Motorsport Games visit www.motorsportgames.com and follow our social media channels: Facebook, Twitter and LinkedIn. About Motorsport Games:Motorsport Games, a Motorsport Network company, combines innovative and engaging video games with exciting esports competitions and content for racing fans and gamers around the globe. The Company is the officially licensed video game developer and publisher for iconic motorsport racing series including NASCAR, 24 Hours of Le Mans and the British Touring Car Championship (“BTCC”). Motorsport Games is an award-winning esports partner of choice for 24 Hours of Le Mans, Formula E, BTCC, the FIA World Rallycross Championship and the eNASCAR Heat Pro League among others.For more information about Motorsport Games visit: www.motorsportgames.com About Luminis and Studio397Luminis International BV is a software and technology company with offices in the Netherlands and the United Kingdom. Our mission is to create exponential value for organizations by using software technology. With 200 colleagues we work with more than 100 customers, including major brands such as KLM, Nike and Bol.com. Luminis also develops cloud-based data solutions under the brands InformationGrid and MediGrid. In 2016 Luminis founded Studio397, aimed specifically at the professional race simulator market. Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as "continue," "will," "may," "could," "should," "expect," "expected," "plans," "intend," "anticipate," "believe," "estimate," "predict," "potential," and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Motorsport Games and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to whether to Motorsport Games will be able to negotiate and enter into the definitive agreements with respect to the acquisition of Studio397 and its rFactor 2 platform, whether all conditions precedent in the definitive agreements to acquire Studio397 and its rFactor 2 platform will be satisfied, whether the closing of such acquisition will occur and whether Motorsport Games will achieve its goals. Additional examples of such risks and uncertainties include, but are not limited to (i) Motorsport Games’ ability (or inability) to maintain existing, and secure additional, licenses and contracts with the sports series; (ii) Motorsport Games’ ability to successfully manage and integrate any joint ventures, acquisitions of businesses, solutions or technologies; (iii) unanticipated operating costs, transaction costs and actual or contingent liabilities; (iv) the ability to attract and retain qualified employees and key personnel; (v) adverse effects of increased competition on Motorsport Games’ business; (vi) the risk that changes in consumer behavior could adversely affect Motorsport Games’ business; (vii) Motorsport Games’ ability to protect its intellectual property; and (viii) local, industry and general business and economic conditions. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent registration statement on Form S-1 and current reports on Form 8-K filed by Motorsport Games with the Securities and Exchange Commission. Motorsport Games anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Motorsport Games assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Motorsport Games’ plans and expectations as of any subsequent date. Press:motorsportgames@astrskpr.com Investors:Ashley DeSimoneAshley.Desimone@icrinc.com
RGAX today announced AURA NEXT, the SaaS-based underwriting decision management platform from Reinsurance Group of America, Incorporated (RGA) and RGAX, completed a Service Organization Control (SOC) 2 Type II examination performed by an external auditing firm.